We observed significant levels of hepatic and muscle IR in NASH subjects, as represented by impaired insulin-mediated suppression of hepatic glucose production and stimulated muscle Gd (weight-adjusted), respectively. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.